PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
125 hedge funds and large institutions have $197M invested in Provention Bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 32 reducing their positions, and 19 closing their positions.
Holders
125
Holders Change
+5
Holders Change %
+4.17%
% of All Funds
2.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
48
Reduced
32
Closed
19
Calls
$8.58M
Puts
$6.67M
Net Calls
+$1.9M
Net Calls Change
-$4.34M
Top Buyers
| 1 |
VA
1
VR Adviser
New York
|
$24.5M |
| 2 |
SC
2
Sessa Capital
New York
|
$23.5M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$11.2M |
| 4 |
4
Millennium Management
New York
|
$4.75M |
| 5 |
PPA
5
Parametric Portfolio Associates
Seattle,
Washington
|
$1.87M |
Top Sellers
| 1 |
GGHC
1
Gilder Gagnon Howe & Co
New York
|
$2.43M |
| 2 |
PA
2
Perceptive Advisors
New York
|
$8M |
| 3 |
3
Two Sigma Advisers
New York
|
$109K |
| 4 |
4
Two Sigma Investments
New York
|
$309K |
| 5 |
6CM
5
683 Capital Management
New York
|
$2.52M |
